Physiology and Pathophysiology of Proteinase-Activated Receptors (PARs): Role of Tryptase/PAR-2 in Vascular Endothelial Barrier Function
Authors:
Open Access
- 1 January 2005
- journal article
- review article
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 97 (1) , 14-19
Abstract
Proteinase-activated receptor-2 (PAR-2) plays important roles in a variety of pathophysiological functions, including inflammatory responses and nociception. In this minireview, we describe the role of PAR-2 in acute inflammatory responses in lungs associated with iodinated radiographic contrast medium (RCM). Intravenous injection of RCM to rats induces lung injury characterized by vascular hyperpermeability, edema, and respiratory depression. Nafamostat, which is found to be the most potent and specific tryptase inhibitor, prevents RCM-induced lung injury. In cultured endothelial cells of human pulmonary artery and bovine aorta, RCM, when applied in combination with mast cells, disrupts barrier function evaluated by the permeability of Evans blue through a monolayer of cultured cells, which is blocked by nafamostat and mimicked by tryptase and PAR-2-activating peptide. The tryptase-induced barrier dysfunction is blocked completely by a phospholipase C inhibitor and partially inhibited by a IP3 receptor blocker, protein kinase C inhibitor, or Rho kinase inhibitor. Morphological observations reveal the formation of actin stress fibers and disappearance of the intercellular meshwork structure of vascular endothelial-cadherin after application of RCM or PAR-2 ligands. Therefore, the release of mast cell tryptase and subsequent activation of endothelial PAR-2 are involved in acute lung injury induced by RCM.Keywords
This publication has 47 references indexed in Scilit:
- Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonistsJournal of Thrombosis and Haemostasis, 2003
- Differential Actions of PAR 2 and PAR 1 in Stimulating Human Endothelial Cell Exocytosis and PermeabilityCirculation Research, 2003
- Comparison of effects of ioxaglate versus iomeprol on histamine and tryptase release in patients with ischemic cardiomyopathyThe American Journal of Cardiology, 2001
- Increased vascular permeability by a specific agonist of protease‐activated receptor‐2 in rat hindpawBritish Journal of Pharmacology, 1998
- Histamine and tryptase in nasal lavage fluid following challenge with methacholine and allergenClinical & Experimental Allergy, 1998
- Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator releaseJournal of Allergy and Clinical Immunology, 1996
- The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin).Journal of Cell Biology, 1995
- In vitro andin vivo studies of radiographic contrast media-induced histamine release in pigsInflammation Research, 1991
- Effect of Iodinated Contrast Media on the Synthesis and Metabolism of Leukotriene B4Investigative Radiology, 1991
- Gabexate Mesylate Inhibition of Serine Proteases: Thermodynamic and Computer-Graphics AnalysisJournal of Pharmaceutical Sciences, 1986